|
27 Jun 2025 |
EPL
|
Consensus Share Price Target
|
241.43 |
304.63 |
- |
26.18 |
buy
|
|
|
|
|
25 May 2017
|
EPL
|
ICICI Securities Limited
|
241.43
|
270.00
|
262.00
(-7.85%)
|
Target met |
Hold
|
|
|
Consolidated revenues witnessed an increase of ~11% YoY to | 634 crore largely on account of ~41% and ~10% YoY increase in revenue of Europe and EAP regions, respectively. However, revenues from Amesa & America region were impacted by demonetisation and lower offtake from key customers, respectively. The company's consolidated business of EDG in Q3FY17 resulted in a sharp rise in revenue from Europe. Revenue contribution of non oral care segment increased from 38.4% to 40.1% during Q4FY17...
|
|
21 Apr 2017
|
EPL
|
CD Equisearch
|
241.43
|
283.00
|
237.90
(1.48%)
|
Target met |
Buy
|
|
|
Income from operations (net of excise) witnessed a increase of 17.9% y-o-y to Rs 588.09 crore ($87.2m) largely on account of 53.7% & 8.7% y-o-y increase in revenue of Europe and Americas regions respectively. However, revenues from AMESA & EAP region grew by just 3.7% & 1.8% on y-o-y basis. EDG Germany became a fully owned subsidiary (associate earlier) of the company with effect from 30th September, 2016. After gaining market share of 34% in oral care segment, Essel has started focusing on huge untapped opportunity in non-oral care segment which is relatively more profitable; however its...
|
|
13 Apr 2017
|
EPL
|
Emkay
|
241.43
|
254.00
|
237.50
(1.65%)
|
Target met |
Hold
|
|
|
We met with the management of Essel Propack to get recent updates on business and strategy for the company going ahead India business has attained normalcy in most of the categories post demonetization barring cosmetic business which is yet to normalize as companies are slow in terms of new launches and waiting for GST rate. China oral care decline for last few quarters have...
|
|
10 Apr 2017
|
EPL
|
Axis Direct
|
241.43
|
256.00
|
238.90
(1.06%)
|
Target met |
Buy
|
|
|
Essel Propack: Increasing revenue share of non-oral care segment, Demonetization impact on Indian operations, Positive outlook for other geographies
|
|
06 Feb 2017
|
EPL
|
Axis Direct
|
241.43
|
272.00
|
253.25
(-4.67%)
|
Target met |
Buy
|
|
|
|
|
06 Feb 2017
|
EPL
|
ICICI Securities Limited
|
241.43
|
270.00
|
253.25
(-4.67%)
|
Target met |
Hold
|
|
|
ICICI Securities Ltd | Retail Equity Research Consolidated revenues witnessed increase of ~17% YoY to | 607 crore (I-direct estimate: ~| 542 crore) largely on account of ~54% and ~9% YoY increase in revenue of Europe, Americas regions respectively. However, revenues from Amesa & EAP region impacted by lower offtake from key customers. Company consolidated business of EDG during Q3FY17 which resulted in sharp rise in revenue from Europe. Revenue contribution of non oral care...
|
|
29 Dec 2016
|
EPL
|
Axis Direct
|
241.43
|
268.00
|
244.00
(-1.05%)
|
Target met |
Buy
|
|
|
|
|
19 Dec 2016
|
EPL
|
Axis Direct
|
241.43
|
268.00
|
250.90
(-3.77%)
|
Target met |
Buy
|
|
|
Essel Propack: Increasing revenue share of non-oral care segment, Likely improvement in RoE could act as re-rating
|
|
28 Oct 2016
|
EPL
|
ICICI Securities Limited
|
241.43
|
257.00
|
240.60
(0.34%)
|
Target met |
Hold
|
|
|
|
|
21 Sep 2016
|
EPL
|
CD Equisearch
|
241.43
|
298.00
|
235.00
(2.74%)
|
Pre-Bonus/ Split |
Buy
|
|
|
To augment its business, Essel Propack counts on the unceasing share of non oral care category of its revenue which is targeted to even the share of oral care in a couple of years. It managed to add spin to its AMESA business last quarter, improving its non oral care share to 50.3% shouldered by strong recovery in cosmetic and pharma category in the Indian market. To bolster its overseas presence, Essel continues to eye on Europe segment which has a huge scope of capacity expansion (acquired 100% stake in Essel Deutschland Germany recently). Q1FY17 didn't turn out well for Europe ...
|